Analysis of Past and Present Synthetic Methodologies on Medicinal Chemistry: Where Have All the New Reactions Gone?

An analysis of chemical reactions used in current medicinal chemistry (2014), three decades ago (1984), and in natural product total synthesis has been conducted. The analysis revealed that of the current most frequently used synthetic reactions, none were discovered within the past 20 years and only two in the 1980s and 1990s (Suzuki-Miyaura and Buchwald-Hartwig). This suggests an inherent high bar of impact for new synthetic reactions in drug discovery. The most frequently used reactions were amide bond formation, Suzuki-Miyaura coupling, and SNAr reactions, most likely due to commercial availability of reagents, high chemoselectivity, and a pressure on delivery. We show that these practices result in overpopulation of certain types of molecular shapes to the exclusion of others using simple PMI plots. We hope that these results will help catalyze improvements in integration of new synthetic methodologies as well as new library design.

[1]  Y. Tohda,et al.  A convenient synthesis of acetylenes: catalytic substitutions of acetylenic hydrogen with bromoalkenes, iodoarenes and bromopyridines , 1975 .

[2]  E. Wünsch,et al.  Di-tert.-butyldicarbonat — ein vorteilhaftes Reagenz zur Einführung der tert.-Butyloxycarbonyl-Schutzgruppe , 1976 .

[3]  D. Le-Nguyen,et al.  PyBOP®: A new peptide coupling reagent devoid of toxic by-product , 1990 .

[4]  K. Nicolaou,et al.  Metathesis reactions in total synthesis. , 2005, Angewandte Chemie.

[5]  Melanie S. Sanford,et al.  Room-temperature C-H arylation: merger of Pd-catalyzed C-H functionalization and visible-light photocatalysis. , 2011, Journal of the American Chemical Society.

[6]  Simon J F Macdonald,et al.  Factors determining the selection of organic reactions by medicinal chemists and the use of these reactions in arrays (small focused libraries). , 2010, Angewandte Chemie.

[7]  M. Yus,et al.  Stereoselective α-aminoallylation of aldehydes with chiral tert-butanesulfinamides and allyl bromides. , 2010, The Journal of organic chemistry.

[8]  J. Tierney,et al.  Microwave assisted organic synthesis-a review , 2001 .

[9]  R. McClain,et al.  9.07 High-Throughput Purification in Support of Pharmaceutical Discovery , 2014 .

[10]  Norio Miyaura,et al.  The Palladium-Catalyzed Cross-Coupling Reaction of Phenylboronic Acid with Haloarenes in the Presence of Bases , 1982 .

[11]  S. Buchwald,et al.  Palladium-Catalyzed Aromatic Aminations with in situ Generated Aminostannanes , 1994 .

[12]  G. Molander,et al.  Potassium trifluoroborate salts as convenient, stable reagents for difficult alkyl transfers. , 2009, Current opinion in drug discovery & development.

[13]  L. A. Carpino.  1-Hydroxy-7-azabenzotriazole. An efficient peptide coupling additive , 1993 .

[14]  J. Ellman,et al.  N-tert-butanesulfinyl imines: versatile intermediates for the asymmetric synthesis of amines. , 2002, Accounts of chemical research.

[15]  P. Nussbaumer.  Medicinal Chemists of the 21st Century—Who Are We and Where to Go? , 2015, ChemMedChem.

[16]  F. Gasparrini,et al.  Expanding the potential of chiral chromatography for high-throughput screening of large compound libraries by means of sub-2μm Whelk-O 1 stationary phase in supercritical fluid conditions. , 2015, Journal of chromatography. A.

[17]  T. Umemoto,et al.  N-Trifluoromethyl-N-nitrosobenzenesulfonamide. A new trifluoromethylating agent. , 1982 .

[18]  M. Desai,et al.  Discovery of ledipasvir (GS-5885): a potent, once-daily oral NS5A inhibitor for the treatment of hepatitis C virus infection. , 2014, Journal of medicinal chemistry.

[19]  J. Bode,et al.  Rethinking amide bond synthesis , 2011, Nature.

[20]  Wolfgang H. B. Sauer,et al.  Molecular Shape Diversity of Combinatorial Libraries: A Prerequisite for Broad Bioactivity , 2003, J. Chem. Inf. Comput. Sci..

[21]  L. Horner,et al.  Phosphororganische Verbindungen, XII. Phosphinoxyde als Olefinierungsreagenzien , 1958 .

[22]  M. A. McClinton,et al.  Trifluoromethylations and related reactions in organic chemistry , 1992 .

[23]  M. Burke,et al.  A simple and modular strategy for small molecule synthesis: iterative Suzuki-Miyaura coupling of B-protected haloboronic acid building blocks. , 2007, Journal of the American Chemical Society.

[24]  D. MacMillan,et al.  Trifluoromethylation of arenes and heteroarenes by means of photoredox catalysis , 2011, Nature.

[25]  R. Kombarov,et al.  Lessons from natural products chemistry can offer novel approaches for synthetic chemistry in drug discovery. , 2012, Journal of medicinal chemistry.

[26]  Allan M Jordan,et al.  The medicinal chemist's toolbox: an analysis of reactions used in the pursuit of drug candidates. , 2011, Journal of medicinal chemistry.

[27]  John P. Overington,et al.  ChEMBL: a large-scale bioactivity database for drug discovery , 2011, Nucleic Acids Res..

[28]  W. Emmons,et al.  The Utility of Phosphonate Carbanions in Olefin Synthesis , 1961 .

[29]  P. Lagüe,et al.  Discovery of a non-estrogenic irreversible inhibitor of 17β-hydroxysteroid dehydrogenase type 1 from 3-substituted-16β-(m-carbamoylbenzyl)-estradiol derivatives. , 2014, Journal of medicinal chemistry.

[30]  Takatoshi Ito,et al.  Cross-coupling reactions of potassium alkyltrifluoroborates with aryl and 1-alkenyl trifluoromethanesulfonates. , 2001, Organic letters.

[31]  P. Baran,et al.  Protecting-group-free synthesis as an opportunity for invention. , 2009, Nature chemistry.

[32]  J. Andrew Grant,et al.  Small Molecule Shape-Fingerprints , 2005, J. Chem. Inf. Model..

[33]  Martin D. Burke,et al.  Synthesis of many different types of organic small molecules using one automated process , 2015, Science.

[34]  M. Burke,et al.  Iterative Cross-Couplng with MIDA Boronates: Towards a General Platform for Small Molecule Synthesis. , 2010, Aldrichimica acta.

[35]  S. Schreiber,et al.  Target-oriented and diversity-oriented organic synthesis in drug discovery. , 2000, Science.

[36]  C. Humblet,et al.  Escape from flatland: increasing saturation as an approach to improving clinical success. , 2009, Journal of medicinal chemistry.

[37]  G. Lloyd‐Jones,et al.  Selection of boron reagents for Suzuki-Miyaura coupling. , 2014, Chemical Society reviews.

[38]  D. Boger,et al.  Total syntheses and initial evaluation of [Ψ[C(═S)NH]Tpg⁴]vancomycin, [Ψ[C(═NH)NH]Tpg⁴]vancomycin, [Ψ[CH₂NH]Tpg⁴]vancomycin, and their (4-chlorobiphenyl)methyl derivatives: synergistic binding pocket and peripheral modifications for the glycopeptide antibiotics. , 2015, Journal of the American Chemical Society.

[39]  H Kubinyi,et al.  Chance favors the prepared mind--from serendipity to rational drug design. , 1999, Journal of receptor and signal transduction research.

[40]  John A. Lowe,et al.  A guide to drug discovery: The role of the medicinal chemist in drug discovery — then and now , 2004, Nature Reviews Drug Discovery.

[41]  Phil S. Baran,et al.  Academia–Industry Symbiosis in Organic Chemistry , 2015, Accounts of chemical research.

[42]  G. Wittig,et al.  Über Triphenyl‐phosphin‐methylene als olefinbildende Reagenzien (I. Mitteil. , 1954 .

[43]  N. Miyaura,et al.  Palladium(0)-Catalyzed Cross-Coupling Reaction of Alkoxydiboron with Haloarenes: A Direct Procedure for Arylboronic Esters , 1995 .

[44]  Guangbin Dong,et al.  Recent applications of arene diazonium salts in organic synthesis. , 2013, Organic & biomolecular chemistry.

[45]  Jean-François Truchon,et al.  Natural products in medicine: transformational outcome of synthetic chemistry. , 2014, Journal of medicinal chemistry.

[46]  J. M. Petrash,et al.  Design of an amide N-glycoside derivative of β-glucogallin: a stable, potent, and specific inhibitor of aldose reductase. , 2014, Journal of medicinal chemistry.

[47]  W Patrick Walters,et al.  What do medicinal chemists actually make? A 50-year retrospective. , 2011, Journal of medicinal chemistry.

[48]  H. Ammon,et al.  Photoinstability of Some Tyrphostin Drugs: Chemical Consequences of Crystallinity , 1995, Pharmaceutical Research.

[49]  Jonas Boström,et al.  Understanding our love affair with p-chlorophenyl: present day implications from historical biases of reagent selection. , 2015, Journal of medicinal chemistry.

[50]  Norio Miyaura,et al.  A new stereospecific cross-coupling by the palladium-catalyzed reaction of 1-alkenylboranes with 1-alkenyl or 1-alkynyl halides , 1980 .

[51]  K I Kaitin,et al.  Deconstructing the Drug Development Process: The New Face of Innovation , 2010, Clinical pharmacology and therapeutics.

[52]  M. Kinch,et al.  An analysis of FDA-approved drugs: natural products and their derivatives. , 2016, Drug discovery today.

[53]  A. Vaz,et al.  A Simple Litmus Test for Aldehyde Oxidase Metabolism of Heteroarenes , 2014, Journal of medicinal chemistry.

[54]  J. Filser,et al.  Metabolic transformation of halogenated and other alkenes--a theoretical approach. Estimation of metabolic reactivities for in vivo conditions. , 1995, Toxicology letters.

[55]  S. Purser,et al.  Fluorine in medicinal chemistry. , 2008, Chemical Society reviews.

[56]  T. Prisinzano,et al.  Synthesis and κ-Opioid Receptor Activity of Furan-Substituted Salvinorin A Analogues , 2014, Journal of medicinal chemistry.

[57]  Robert H. Grubbs,et al.  New Approaches to Olefin Cross-Metathesis , 2000 .

[58]  Stefan Wetzel,et al.  Natural-product-derived fragments for fragment-based ligand discovery , 2012, Nature Chemistry.

[59]  R. Grubbs,et al.  A general model for selectivity in olefin cross metathesis. , 2003, Journal of the American Chemical Society.

[60]  J. Ellman,et al.  Synthesis and applications of tert-butanesulfinamide. , 2010, Chemical reviews.

[61]  S. Buchwald,et al.  A Simple Catalytic Method for the Conversion of Aryl Bromides to Arylamines , 1995 .

[62]  N. Miyaura,et al.  Synthesis of pinacol arylboronates via cross-coupling reaction of bis(pinacolato)diboron with chloroarenes catalyzed by palladium(0)–tricyclohexylphosphine complexes , 2001 .

[63]  Norio Miyaura,et al.  Stereoselective synthesis of arylated (E)-alkenes by the reaction of alk-1-enylboranes with aryl halides in the presence of palladium catalyst , 1979 .

[64]  P. Karoyan,et al.  Amino-zinc-ene-enolate cyclization: a short access to cis-3-substituted prolino-homotryptophane derivatives. , 2008, The Journal of organic chemistry.

[65]  J. Hartwig,et al.  Palladium-catalyzed formation of carbon-nitrogen bonds. Reaction intermediates and catalyst improvements in the hetero cross-coupling of aryl halides and tin amides , 1994 .

[66]  M. G. Campbell,et al.  Late-Stage Fluorination: From Fundamentals to Application , 2014, Organic process research & development.

[67]  A. Suzuki.  Cross-coupling reactions of organoboranes: an easy way to construct C-C bonds (Nobel Lecture). , 2011, Angewandte Chemie.

[68]  Lionel Colliandre,et al.  e-Drug3D: 3D structure collections dedicated to drug repurposing and fragment-based drug design , 2012, Bioinform..

[69]  F. Albericio,et al.  COMU: a safer and more effective replacement for benzotriazole-based uronium coupling reagents. , 2009, Chemistry.

[70]  Michael S Lajiness,et al.  Assessment of the consistency of medicinal chemists in reviewing sets of compounds. , 2004, Journal of medicinal chemistry.

[71]  L. Sternbach.  The benzodiazepine story. , 1983, Journal of psychoactive drugs.

[72]  A. Jeltsch,et al.  Synthesis and evaluation of analogues of N-phthaloyl-l-tryptophan (RG108) as inhibitors of DNA methyltransferase 1. , 2014, Journal of medicinal chemistry.

[73]  T. Molinski,et al.  Potent Fluorinated Agelastatin Analogues for Chronic Lymphocytic Leukemia: Design, Synthesis, and Pharmacokinetic Studies , 2014, Journal of medicinal chemistry.

[74]  James R. Moore,et al.  Efficient Synthesis of Losartan, A Nonpeptide Angiotensin II Receptor Antagonist , 1994 .

[75]  P. Baran,et al.  Total synthesis of marine natural products without using protecting groups , 2007, Nature.

[76]  Paul S. Riehl,et al.  Discovery of Novel Synthetic Methodologies and Reagents during Natural Product Synthesis in the Post-Palytoxin Era. , 2015, Chemical reviews.

[77]  E. Hopper-Borge,et al.  Synthesis and Biological Evaluation of Pentacyclic Strychnos Alkaloids as Selective Modulators of the ABCC10 (MRP7) Efflux Pump , 2014, Journal of medicinal chemistry.

[78]  J. S. Carey,et al.  Analysis of the reactions used for the preparation of drug candidate molecules. , 2006, Organic & biomolecular chemistry.

[79]  Katharine Sanderson.  March of the synthesis machines , 2015, Nature Reviews Drug Discovery.